Form 4: Dentsply Sirona Executive Brian T. Gladden Reports Acquisition of Restricted Stock Units

Brian T. Gladden, an executive at Dentsply Sirona, reported the acquisition of 7,994 Restricted Stock Units (RSUs) on May 23, 2024, which vest in full one year from the grant date.

Summary

• On May 23, 2024, Brian T. Gladden, an executive at Dentsply Sirona Inc. [XRAY], acquired 7,994 Restricted Stock Units (RSUs).
• These RSUs vest in full one year from the date of the grant.
• Following this transaction, Gladden directly owns 13,958.616 shares of common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing related to executive compensation. The acquisition of RSUs can be seen as a slightly positive sign, indicating confidence, but it's not a major event.

Positives

• The acquisition of RSUs by an executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure related to executive compensation and is common in publicly traded companies. It reflects part of Dentsply Sirona's compensation strategy to align executive interests with shareholder value.

Comparison to Industry Standards

• Executive compensation packages including RSUs are a standard practice among publicly traded companies, particularly in the healthcare and technology sectors.
• Companies like Align Technology (ALGN) and Straumann (STMN.SW) also utilize RSUs as part of their executive compensation plans to incentivize performance and retention.
• The vesting schedule of one year is fairly standard, although some companies may use longer vesting periods to further align executive interests with long-term shareholder value.

Stakeholder Impact

• The granting of RSUs aligns executive interests with those of shareholders, potentially incentivizing actions that increase shareholder value.

Key Dates